Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy
The graduating cohort comprised seven batches across five specialized programs
Dr. Jain brings extensive experience in the biotech and pharma sectors and has been instrumental in driving innovation, vaccine development, and healthcare advancement
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The private funding rose 38% amid growing international collaborations and CDMO demand
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
Angelini Ventures has already invested €125 million in 22 startups
India currently hosts more than 10,075 biotech startups
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
